2020M&A Transaction Multiples
Pharmacy Multiples - 2020
Sourced from 16 publicly disclosed Pharmacy acquisitions in 2020. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
10.5x
median · p25 8.2x - p75 12.8x · n=7
EV / Revenue
1.0x
median · p25 0.7x - p75 3.7x · n=14
Value your Pharmacy business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Pharmacy multiples by year
Other verticals - 2020 multiples
Aerospace· 13x EBITDAConsulting· 8.54x EBITDAConsumer Products· 12.71x EBITDAElectronics· 10x EBITDAFood Manufacturing· 1.9x RevGaming· 11.94x EBITDAHealthcare IT· 17.5x EBITDAHome Health· 6.6x EBITDAHospice· 15x EBITDAIndustrial Equipment· 11.7x EBITDAIT Services· 7.88x EBITDAMedical Devices· 25.9x EBITDAMedical Practice Primary Care· 13.3x EBITDAMedical Practice Specialty· 9.5x EBITDAMental Health· 11x EBITDAMetal Fabrication· 5.5x EBITDAOil Gas Services· 5.12x EBITDAOther· 16.1x EBITDAOther Healthcare· 11.1x EBITDAOther Manufacturing· 8.36x EBITDAOther Personal Services· 16.66x EBITDAOther Professional Services· 7.38x EBITDAOther Technology· 15.23x EBITDARestaurant Qsr· 12.58x EBITDA
Data sourced from 16 disclosed Pharmacy M&A transactions in 2020. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →